Pages that link to "Q41187750"
Jump to navigation
Jump to search
The following pages link to Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells (Q41187750):
Displayed 50 items.
- Molecular organization of sarcoglycan complex in mouse myotubes in culture (Q24685886) (← links)
- Intramuscular electroporation with the pro-opiomelanocortin gene in rat adjuvant arthritis (Q24792890) (← links)
- The adenovirus genome contributes to the structural stability of the virion (Q26825101) (← links)
- Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy (Q28084979) (← links)
- Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular Dystrophy (Q28474542) (← links)
- Expanded-capacity adenoviral vectors--the helper-dependent vectors (Q33544035) (← links)
- Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors. (Q33818929) (← links)
- Generation of adenovirus vectors devoid of all viral genes by recombination between inverted repeats (Q33823132) (← links)
- Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons (Q33825579) (← links)
- Gene and cell-mediated therapies for muscular dystrophy. (Q33831193) (← links)
- Transfer of the full-length dystrophin-coding sequence into muscle cells by a dual high-capacity hybrid viral vector with site-specific integration ability (Q33834104) (← links)
- Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector (Q33949311) (← links)
- Improvements in adenoviral vector technology: overcoming barriers for gene therapy (Q34005922) (← links)
- Adenovirus vectors for human gene therapy (Q34070158) (← links)
- Production of first generation adenovirus vectors: a review (Q34085243) (← links)
- Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin. (Q34190967) (← links)
- Novel approaches to treat muscular dystrophies (Q34204364) (← links)
- Adenovirus mediated gene transfer to skeletal muscle (Q34733229) (← links)
- Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD? (Q34807072) (← links)
- Viral vectors for gene transfer of micro-, mini-, or full-length dystrophin (Q34807084) (← links)
- Strategies for muscle-specific targeting of adenoviral gene transfer vectors (Q34807096) (← links)
- Optimization of the helper-dependent adenovirus system for production and potency in vivo (Q34996749) (← links)
- Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. (Q35057135) (← links)
- In vivo gene therapy for diabetes mellitus (Q35558681) (← links)
- Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances (Q35847178) (← links)
- A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging. (Q35881805) (← links)
- Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver (Q35895708) (← links)
- Persistence in muscle of an adenoviral vector that lacks all viral genes (Q36018705) (← links)
- An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene (Q36163092) (← links)
- Adenoviral vectors: development and application (Q36179657) (← links)
- Development of approaches to improve cell survival in myoblast transfer therapy (Q36290641) (← links)
- Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. (Q36310768) (← links)
- Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons (Q36557727) (← links)
- Emerging strategies for cell and gene therapy of the muscular dystrophies (Q36960845) (← links)
- Barriers for retinal gene therapy: separating fact from fiction (Q37195446) (← links)
- Designing heart performance by gene transfer. (Q37299072) (← links)
- Gene therapy in animal models of autosomal dominant retinitis pigmentosa (Q38053151) (← links)
- Fusion of HIV-1 Tat protein transduction domain to poly-lysine as a new DNA delivery tool (Q38797666) (← links)
- Mutational analysis of the avian adenovirus CELO, which provides a basis for gene delivery vectors. (Q39549432) (← links)
- Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase (Q39551150) (← links)
- Frequency and stability of chromosomal integration of adenovirus vectors (Q39594975) (← links)
- Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-kilobase genomic stuffer (Q39604468) (← links)
- Role for the adenovirus IVa2 protein in packaging of viral DNA (Q39604759) (← links)
- Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted (Q39642143) (← links)
- Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication. (Q39882372) (← links)
- A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses (Q39906552) (← links)
- Robust hepatic gene silencing for functional studies using helper-dependent adenoviral vectors. (Q39933737) (← links)
- Therapeutic strategies for the inherited neuropathies. (Q40316169) (← links)
- Application of an immunoperoxidase monolayer assay for the detection of arboviral antibodies (Q40651385) (← links)
- Intracerebral transplantation and successful integration of astrocytes following genetic modification with a high-capacity adenoviral vector (Q40678861) (← links)